Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11993588 Crystalline forms of a MAGL inhibitor

Overview Structured Data Issues Contributors Activity

Is a

1

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

1

Patent Number

Patent Inventor Names

Todd K. Jones1

Cheryl A. Grice1

Channing Rodney Beals1

Kurt G. Grimm1

Jacqueline Lorayne Blankman1

Date of Patent

May 28, 2024

1

Patent Application Number

174695351

Date Filed

September 8, 2021

1

Patent Citations

US Patent 9487495 Carbamate compounds and of making and using same

1

US Patent 10463753 Radiolabeled monoacylglycerol lipase occupancy probe

1

US Patent 10450302 Methods of treating inflammation or neuropathic pain

1

US Patent 11034674 Methods of treating inflammation or neuropathic pain

1

US Patent 6932983 Porous drug matrices and methods of manufacture thereof

1

US Patent 9133148 Carbamate compounds and of making and using same

1

Patent Primary Examiner

1

Patent abstract

Described herein is the MAGL inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate, including crystalline forms and pharmaceutically acceptable salts and solvates thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11993588 Crystalline forms of a MAGL inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool